Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2001

01-05-2001 | Rapid Communication

Effect of Additional Chromosomal Abnormalities in Acute Promyelocytic Leukemia Treated With All-trans-Retinoic Acid: A Report of 17 Patients

Authors: Yasushi Okoshi, Hideki Akiyama, Natsu Kono, Tomoko Matsumura, Daisuke Mizuchi, Shin-Ichiro Mori, Kazuteru Ohashi, Hisashi Sakamaki

Published in: International Journal of Hematology | Issue 4/2001

Login to get access
Metadata
Title
Effect of Additional Chromosomal Abnormalities in Acute Promyelocytic Leukemia Treated With All-trans-Retinoic Acid: A Report of 17 Patients
Authors
Yasushi Okoshi
Hideki Akiyama
Natsu Kono
Tomoko Matsumura
Daisuke Mizuchi
Shin-Ichiro Mori
Kazuteru Ohashi
Hisashi Sakamaki
Publication date
01-05-2001
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2001
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02994013

Other articles of this Issue 4/2001

International Journal of Hematology 4/2001 Go to the issue

Rapid Communication

Significant Association Between Expression of the CD11b Surface Molecule and Favorable Outcome for Patients With Acute Myeloblastic Leukemia

Rapid Communication

Clinical Trial to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Recombinant Factor VIIa in Japanese Patients With Hemophilia With Inhibitors

Rapid Communication

Paratracheal Extramedullary Hematopoiesis

Review Article

Differentiation, Apoptosis, and Function of Human Immature and Mature Myeloid Cells: Intracellular Signaling Mechanism

Rapid Communication

Defective Megakaryopoiesis and Abnormal Erythroid Development inFli-1 Gene-Targeted Mice

OriginalPaper

Epidemiological Features of Myelodysplastic Syndromes: Results From Regional Cancer Surveys and Hospital-Based Statistics
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits